In the latest trading session, Astrazeneca (AZN) closed at $163.78, marking a +2.25% move from the previous day.
AstraZeneca’s AZN second-quarter 2025 core earnings of $1.09 per American depositary share (ADS) came in line with the Zacks Consensus Estimate. Core earnings of $2.17 per share rose 10% year over ...